FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named
This article was originally published in The Tan Sheet
Executive Summary
FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill